{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Amgen Faces “Uphill Battle” in Defending Antibody Genus Patentability",
    "url": "https://www.lexblog.com/2021/02/11/amgen-faces-uphill-battle-in-defending-antibody-genus-patentability/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-PCNZPM8A",
        "url": "https://www.lexblog.com/lib/PCNZPM8A/"
    },
    "datePublished": "2021-02-11T10:22:39-05:00",
    "dateModified": "2021-10-26T10:44:18-04:00",
    "author": {
        "@type": "Person",
        "name": "Caitlin M. Wilmot"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Rothwell Figg"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Biosimilars Law Bulletin",
    "about": "Intellectual Property",
    "sourceUrl": "https://www.biosimilarsip.com/?p=5420",
    "sourceStability": "may-move"
}